ACS Short Term Mortality Prediction Tool

ACS Short Term Mortality Prediction Tool Explanation And Clinical Context This tool summarizes short term mortality and ischemic risk estimation for patients with acute coronary syndromes based on guideline supported risk scores. The 2025 American Heart Association acute coronary syndromes guideline highlights that risk for early death and major adverse cardiac events varies widely among patients and that structured risk assessment can support bedside decisions for reperfusion strategy intensity of monitoring and follow up care. The guideline endorses use of the GRACE risk score and the TIMI risk scores for unstable angina or non ST elevation myocardial infarction and for ST elevation myocardial infarction as well validated instruments that use routinely available clinical and laboratory variables for individualized risk stratification in established acute coronary syndromes cohorts.

For patients with unstable angina or non ST elevation myocardial infarction the TIMI risk score assigns one point for each of seven features age sixty five years or older at least three traditional coronary artery disease risk factors known coronary stenosis of at least fifty percent on prior angiography use of aspirin in the prior seven days at least two anginal episodes in the prior twenty four hours ST segment deviation on the presenting electrocardiogram and elevated cardiac biomarkers. The total score ranges from zero to seven and correlates with the combined fourteen day risk of death myocardial infarction or urgent revascularization. Higher scores identify patients with a greater short term ischemic and mortality risk which may support decisions regarding early invasive strategy and intensity of pharmacologic therapy when integrated with clinical judgment and bleeding risk assessment.

For patients with ST elevation myocardial infarction the TIMI risk score uses nine baseline variables to estimate thirty day all cause mortality age category Killip class systolic blood pressure heart rate presence of anterior ST segment elevation or left bundle branch block history of diabetes hypertension or angina low body weight and time from symptom onset to treatment greater than four hours. Each feature contributes a specific number of points to a total score that ranges from zero to fourteen. Increasing score is associated with a stepwise increase in early mortality risk in the original validation cohort and the 2025 guideline lists this score as a practical bedside tool to frame prognosis at presentation and to communicate risk with patients and families.

Although the GRACE risk score is not explicitly calculated in this implementation the guideline emphasizes that GRACE provides robust estimation of in hospital and six month risk of death or death and myocardial infarction for a broad acute coronary syndromes population and has demonstrated superiority over subjective physician assessment in several studies. In practice clinicians may use GRACE TIMI and other context specific tools together with markers of heart failure such as Killip class and pulmonary congestion troponin concentration natriuretic peptide levels and lung ultrasound findings to refine overall risk stratification. Regardless of the specific tool chosen guideline authors caution that these scores should complement rather than replace clinical judgment and should not be used as diagnostic instruments but as aids for prognosis and shared decision making.

In summary this calculator operationalizes the TIMI scores that are highlighted in the 2025 acute coronary syndromes guideline for early estimation of short term mortality and ischemic risk. It is intended for adult patients with established or strongly suspected unstable angina non ST elevation myocardial infarction or ST elevation myocardial infarction and should be interpreted in conjunction with the complete clinical picture electrocardiographic findings biomarker trends and patient preferences when planning reperfusion strategy monitoring level and discharge timing.